Skip to main content
Top

24-02-2024 | Gestational Diabetes | Original Article

Incidence of overt diabetes in pregnancy among women with 50-g glucose challenge test ≥ 200 mg/dL

Authors: Dittakarn Boriboonhirunsarn, Amporn Robkhonburi, Dawrueng Gusonkhum

Published in: Diabetology International

Login to get access

Abstract

Objectives

To determine the incidence of overt diabetes in pregnancy (ODIP) among women with 50-g GCT results ≥ 200 mg/dL and compare characteristics and pregnancy outcomes between women with and without gestational diabetes (GDM).

Methods

A retrospective cohort study was conducted in 212 pregnant women whose 50-g GCT results ≥ 200 mg/dL. ODIP was diagnosed from 75-g OGTT if fasting plasma glucose ≥ 126 and/or 2-h plasma glucose ≥ 200 mg/dL. Various characteristics and pregnancy outcomes were compared between ODIP and those with and without GDM.

Results

Incidence of ODIP was 1.9% of all pregnant women and 23.6% of women with 50-g GCT ≥ 200 mg/dL. Women with ODIP and GDM were more likely to be overweight or obese than those without GDM (52%, 39.6%, and 18.2%, p < 0.001). Women with ODIP had significantly higher 50-g GCT results, lower gestational weight gain, and were less likely to deliver vaginally. Insulin therapy was significantly more common in women with ODIP compared to GDM (70.2% vs. 15.4%, p < 0.001). Rates of LGA, macrosomia, and other neonatal outcomes were comparable. BMI ≥ 25 kg/m2 and 50-g GCT ≥ 240 mg/dL independently increased the risk of any abnormal glucose tolerance [adjusted OR 3.22 (95% CI 1.55–6.70) and 2.28 (95% CI 1.14–4.58)] and ODIP [adjusted OR 9.43 (95% CI 2.15–41.38) and 6.36 (95% CI 2.85–14.18)], respectively.

Conclusion

Incidence of ODIP was 23.6% of women with 50-g GCT ≥ 200 mg/dL. BMI ≥ 25 kg/m2 and 50-g GCT ≥ 240 mg/dL independently increased the risk of GDM and ODIP. Neonatal complications were comparable between ODIP and those with and without GDM.
Literature
1.
go back to reference ACOG Practice Bulletin No. 201: Pregestational diabetes mellitus. Obstet Gynecol. 2018;132(6):e228–48.CrossRef ACOG Practice Bulletin No. 201: Pregestational diabetes mellitus. Obstet Gynecol. 2018;132(6):e228–48.CrossRef
2.
go back to reference American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes. Diabetes Care. 2023;46(Suppl 6):S19–40. American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes. Diabetes Care. 2023;46(Suppl 6):S19–40.
3.
go back to reference Hod M, Kapur A, Sacks DA, Hadar E, Agarwal M, Di Renzo GC, et al. The international federation of gynecology and obstetrics (FIGO) Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet. 2015;131(Suppl 3):S173-211.CrossRefPubMed Hod M, Kapur A, Sacks DA, Hadar E, Agarwal M, Di Renzo GC, et al. The international federation of gynecology and obstetrics (FIGO) Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet. 2015;131(Suppl 3):S173-211.CrossRefPubMed
4.
go back to reference World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a world health organization guideline. Diabetes Res Clin Pract. 2014;103(3):341–63.CrossRef World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a world health organization guideline. Diabetes Res Clin Pract. 2014;103(3):341–63.CrossRef
6.
go back to reference International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676–82.CrossRefPubMedCentral International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676–82.CrossRefPubMedCentral
7.
go back to reference Oppermann ML, Campos MA, Hirakata VN, Reichelt AJ. Overt diabetes imposes a comparable burden on outcomes as pregestational diabetes: a cohort study. Diabetol Metab Syndr. 2022;14(1):177.CrossRefPubMedPubMedCentral Oppermann ML, Campos MA, Hirakata VN, Reichelt AJ. Overt diabetes imposes a comparable burden on outcomes as pregestational diabetes: a cohort study. Diabetol Metab Syndr. 2022;14(1):177.CrossRefPubMedPubMedCentral
8.
go back to reference Lee D, Booth GL, Ray JG, Ling V, Feig DS. Undiagnosed type 2 diabetes during pregnancy is associated with increased perinatal mortality: a large population-based cohort study in Ontario. Canada Diabet Med. 2020;37(10):1696–704.CrossRefPubMed Lee D, Booth GL, Ray JG, Ling V, Feig DS. Undiagnosed type 2 diabetes during pregnancy is associated with increased perinatal mortality: a large population-based cohort study in Ontario. Canada Diabet Med. 2020;37(10):1696–704.CrossRefPubMed
9.
go back to reference Murphy HR, Howgate C, O’Keefe J, Myers J, Morgan M, Coleman MA, et al. Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort study. Lancet Diabetes Endocrinol. 2021;9(3):153–64.CrossRefPubMed Murphy HR, Howgate C, O’Keefe J, Myers J, Morgan M, Coleman MA, et al. Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort study. Lancet Diabetes Endocrinol. 2021;9(3):153–64.CrossRefPubMed
10.
go back to reference Wong T, Ross GP, Jalaludin BB, Flack JR. The clinical significance of overt diabetes in pregnancy. Diabet Med. 2013;30(4):468–74.CrossRefPubMed Wong T, Ross GP, Jalaludin BB, Flack JR. The clinical significance of overt diabetes in pregnancy. Diabet Med. 2013;30(4):468–74.CrossRefPubMed
11.
go back to reference Mane L, Flores-Le Roux JA, Benaiges D, Chillaron JJ, Prados M, Pedro-Botet J, et al. Impact of overt diabetes diagnosed in pregnancy in a multi-ethnic cohort in Spain. Gynecol Endocrinol. 2019;35(4):332–6.CrossRefPubMed Mane L, Flores-Le Roux JA, Benaiges D, Chillaron JJ, Prados M, Pedro-Botet J, et al. Impact of overt diabetes diagnosed in pregnancy in a multi-ethnic cohort in Spain. Gynecol Endocrinol. 2019;35(4):332–6.CrossRefPubMed
12.
go back to reference Sampaio Y, Porto LB, Lauand TCG, Marcon LP, Pedrosa HC. Gestational diabetes and overt diabetes first diagnosed in pregnancy: characteristics, therapeutic approach and perinatal outcomes in a public healthcare referral center in Brazil. Arch Endocrinol Metab. 2021;65(1):79–84.PubMed Sampaio Y, Porto LB, Lauand TCG, Marcon LP, Pedrosa HC. Gestational diabetes and overt diabetes first diagnosed in pregnancy: characteristics, therapeutic approach and perinatal outcomes in a public healthcare referral center in Brazil. Arch Endocrinol Metab. 2021;65(1):79–84.PubMed
13.
go back to reference Milln J, Nakabuye B, Natamba BK, Sekitoleko I, Mubiru M, Namara AA, et al. Antenatal management and maternal/fetal outcomes associated with hyperglycaemia in pregnancy (HIP) in Uganda; a prospective cohort study. BMC Pregnancy Childbirth. 2021;21(1):386.CrossRefPubMedPubMedCentral Milln J, Nakabuye B, Natamba BK, Sekitoleko I, Mubiru M, Namara AA, et al. Antenatal management and maternal/fetal outcomes associated with hyperglycaemia in pregnancy (HIP) in Uganda; a prospective cohort study. BMC Pregnancy Childbirth. 2021;21(1):386.CrossRefPubMedPubMedCentral
14.
go back to reference Sugiyama T, Saito M, Nishigori H, Nagase S, Yaegashi N, Sagawa N, et al. Comparison of pregnancy outcomes between women with gestational diabetes and overt diabetes first diagnosed in pregnancy: a retrospective multi-institutional study in Japan. Diabetes Res Clin Pract. 2014;103(1):20–5.CrossRefPubMed Sugiyama T, Saito M, Nishigori H, Nagase S, Yaegashi N, Sagawa N, et al. Comparison of pregnancy outcomes between women with gestational diabetes and overt diabetes first diagnosed in pregnancy: a retrospective multi-institutional study in Japan. Diabetes Res Clin Pract. 2014;103(1):20–5.CrossRefPubMed
15.
go back to reference Park S, Kim SH. Women with rigorously managed overt diabetes during pregnancy do not experience adverse infant outcomes but do remain at serious risk of postpartum diabetes. Endocr J. 2015;62(4):319–27.CrossRefPubMed Park S, Kim SH. Women with rigorously managed overt diabetes during pregnancy do not experience adverse infant outcomes but do remain at serious risk of postpartum diabetes. Endocr J. 2015;62(4):319–27.CrossRefPubMed
16.
go back to reference Kannawat S, Chawanpaiboon S, Boriboonhirunsarn D. Pregnancy and neonatal adverse outcomes in women with gestational diabetes mellitus diagnosed by a 50-g glucose challenge test level ≥ 200 mg/dl compared with test results using the 100-g oral glucose tolerance test and Carpenter-Coustan criteria. Thai J Obstet Gynaecol. 2021;29(3):142–50. Kannawat S, Chawanpaiboon S, Boriboonhirunsarn D. Pregnancy and neonatal adverse outcomes in women with gestational diabetes mellitus diagnosed by a 50-g glucose challenge test level ≥ 200 mg/dl compared with test results using the 100-g oral glucose tolerance test and Carpenter-Coustan criteria. Thai J Obstet Gynaecol. 2021;29(3):142–50.
17.
go back to reference Kaewsrinual S, Boriboonhirunsarn D. Risk factors for insulin therapy in gestational diabetes mellitus. Thai J Obstet Gynaecol. 2022;30(1):51–9. Kaewsrinual S, Boriboonhirunsarn D. Risk factors for insulin therapy in gestational diabetes mellitus. Thai J Obstet Gynaecol. 2022;30(1):51–9.
18.
go back to reference Phattanachindakun B, Watananirun K, Boriboonhirunsarn D. Early universal screening of gestational diabetes in a university hospital in Thailand. J Obstet Gynaecol. 2022;42(6):2001–7.CrossRefPubMed Phattanachindakun B, Watananirun K, Boriboonhirunsarn D. Early universal screening of gestational diabetes in a university hospital in Thailand. J Obstet Gynaecol. 2022;42(6):2001–7.CrossRefPubMed
19.
go back to reference Rasmussen KM, Yaktine AL, editors. Weight gain during pregnancy: Reexamining the guidelines. Washington, DC: The National Academies Press; 2009. Rasmussen KM, Yaktine AL, editors. Weight gain during pregnancy: Reexamining the guidelines. Washington, DC: The National Academies Press; 2009.
20.
go back to reference Gestational hypertension and preeclampsia. ACOG practice bulletin, number 222. Obstet Gynecol. 2020;135(6):e237–60.CrossRef Gestational hypertension and preeclampsia. ACOG practice bulletin, number 222. Obstet Gynecol. 2020;135(6):e237–60.CrossRef
21.
go back to reference Mikolajczyk RT, Zhang J, Betran AP, Souza JP, Mori R, Gulmezoglu AM, Merialdi M. A global reference for fetal-weight and birthweight percentiles. Lancet. 2011;377(9780):1855–61.CrossRefPubMed Mikolajczyk RT, Zhang J, Betran AP, Souza JP, Mori R, Gulmezoglu AM, Merialdi M. A global reference for fetal-weight and birthweight percentiles. Lancet. 2011;377(9780):1855–61.CrossRefPubMed
Metadata
Title
Incidence of overt diabetes in pregnancy among women with 50-g glucose challenge test ≥ 200 mg/dL
Authors
Dittakarn Boriboonhirunsarn
Amporn Robkhonburi
Dawrueng Gusonkhum
Publication date
24-02-2024
Publisher
Springer Nature Singapore
Published in
Diabetology International
Print ISSN: 2190-1678
Electronic ISSN: 2190-1686
DOI
https://doi.org/10.1007/s13340-024-00694-w